Assessment of MRI issues for the Argus II Retinal Prosthesis

Magnetic Resonance Imaging

Volumn 30, Issue 3, 2012, Pages 382-389

  Weiland, James D ^a   Faraji, Boozarjomehr ^b   Greenberg, Robert J ^b   Humayun, Mark S ^a   Shellock, Frank G ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Second Sight Medical Products Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Magnetic resonance imaging; MRI, artifacts; MRI, implants; Retinal prosthesis; Safety

Indexed keywords

ARTICLE; ARTIFACT; CONTROLLED STUDY; DEVICE SAFETY; HEATING; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTHESIS; RETINA PROSTHESIS; TORQUE;

ARTIFACTS; EQUIPMENT SAFETY; HOT TEMPERATURE; HUMANS; MAGNETIC RESONANCE IMAGING; PHANTOMS, IMAGING; RISK ASSESSMENT; TORQUE; VISUAL PROSTHESIS;

EID: 84857113243     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.12.005     Document Type: Article

References (20)

1. Weiland J.D., Liu W., Humayun M.S. Retinal prosthesis. Annu Rev Biomed Eng 2005, 7:361-401.
2. Roessler G., Laube T., Brockmann C., Kirschkamp T., Mazinani B., et al. Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial. Invest Ophthalmol Vis Sci 2009, 50:3003-3008.
3. Zrenner E., Bartz-Schmidt K.U., Benav H., Besch D., Bruckmann A., et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 2011, 278:1489-1497.
4. Yanai D., Weiland J.D., Mahadevappa M., Greenberg R.J., Fine I., Humayun M.S. Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa. Am J Ophthalmol 2007, 143:820-827.
5. Ahuja A.K., Dorn J.D., Caspi A., McMahon M.J., Dagnelie G., Dacruz L., et al. Argus II Study Group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol 2011, 95:539-543.
6. Humayun M.S., Dorn J.D., Ahuja A.K., Caspi A., Filley E., Dagnelie G., et al. Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility study. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:4566-4568.
7. Rezai A.R., Finelli D., Nyenhuis J.A., Hrdlick G., Tkach J., Ruggieri P., et al. Neurostimulator for deep brain stimulation: ex vivo evaluation of MRI-related heating at 1.5-tesla. J Magn Reson Imaging 2002, 15:241-250.
8. Finelli D.A., Rezai A.R., Ruggieri P., Tkach J., Nyenhuis J., et al. MR-related heating of deep brain stimulation electrodes: an in vitro study of clinical imaging sequences. Am J Neuroradiol 2002, 23:1795-1802.
9. Shellock F.G., Cosendai G., Park S.M., Nyenhuis J.A. Implantable microstimulator magnetic resonance safety at 1.5-tesla. Invest Radiol 2004, 39:591-599.
10. Bhidayasiri R., Bronstein J.M., Sinha S., et al. Bilateral neurostimulation systems used for deep brain stimulation: in vitro study of MRI-related heating at 1.5-tesla and implications for clinical imaging of the brain. Magn Reson Imaging 2005, 23:549-555.
11. Nyenhuis J.A., Park S.M., Kamondetdacha R., Amjad A., Shellock F.G., Rezai A. MRI and implanted medical devices: basic interactions with an emphasis on heating. IEEE Trans Device Mater Reliab 2005, 5:467-478.
12. Begnaud J., Inman D.M. VNS therapy system: in vitro evaluation of MRI-related heating and function at 1.5- and 3-tesla. Neuromodulation 2006, 9:204-213.
13. Shellock F.G., Crivelli R., Venugopalan R. Programmable infusion pump and catheter: evaluation using 3-tesla MRI. Neuromodulation 2008, 11:163-170.
14. Shellock F.G. MRI safety and neuromodulation systems. Neuromodulation 2009, Academic Press/Elsevier, New York. E.S. Krames, P.H. Peckham, A.R. Rezai (Eds.).
15. Shellock F.G. Reference manual for magnetic resonance safety, implants, and devices: 2012 edition 2012, Biomedical Research Publishing Group, Los Angeles, CA.
16. Shellock F.G., Valencerina S. In vitro evaluation of MR imaging issues at 3-T for aneurysm clips made from MP35N: findings and information applied to 155 additional aneurysm clips. AJNR Am J Neuroradiology 2010, 31:615-619.
17. Shellock F.G., Valencerina S. Ventricular assist implant (AB5000): in vitro assessment of MRI issues at 3-tesla. J Cardiovasc Magn Reson 2008, 10:23-30.
18. Shellock F.G., Kanal E., Gilk T. Confusion regarding the value reported for the term "spatial gradient magnetic field" and how this information is applied to labeling of medical implants and devices. Am J Roentgenol 2011, 196:142-145.
19. American Society for Testing and Materials (ASTM) Designation: F 2052-06, standard test method for measurement of magnetically induced displacement force on passive implants in the magnetic resonance environment. In: Annual book of ASTM standards, section 13, medical devices and services, volume 13.01 medical devices; emergency medical services. West Conshohocken, PA.
20. Shellock F.G., Woods T.O., Crues J.V. MRI labeling information for implants and devices: explanation of terminology. Radiology 2009, 253:26-30.